{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:53:12Z","timestamp":1791337992335,"version":"4.3.1"},"reference-count":46,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Genetic testing for 21-hydroxylase deficiency (21OHD) is advantageous when hormonal testing is equivocal, to molecularly confirm diagnosis, and for genetic counseling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the clinical and biochemical phenotype across the genotypic spectrum of 21OHD in a large cohort using updated genetic methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective study of 457 individuals with 21OHD enrolled in a Natural History Study at the National Institutes of Health Clinical Center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority (79%) were compound heterozygous, 46% with chimeric alleles\/30-kb deletions including 2.6% with attenuated chimeras, 10.1% with CAH-X (33% with cardiac defects), and 3.7% with genotype-phenotype discordance. The most common mutations among individuals with salt-wasting, simple-virilizing, and nonclassic (NC) phenotypes were In2G, I172N, and V281L, respectively. Rare or novel mutations accounted for 4.3% alleles, 0.33% arose de novo. 17OHP levels at diagnosis varied by genotype group (Null &amp;gt; In2G &amp;gt; simple-virilizing genotypes &amp;gt; P30L &amp;gt; Other NC; P &amp;lt; .001); but maximum values obtained during clinical care over time were similar among all classic and among all NC genotypes. Individuals with P30L had higher 17OHP and lower cortisol at diagnosis compared to other NC genotypes (P &amp;lt; .001) and were more likely to have basal 17OHP &amp;gt;1000\u2005ng\/dL (P &amp;lt; .001). Individuals with cryptic NC CAH had lower 17OHP after cosyntropin stimulation compared to those with symptomatic NC CAH (P = .02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A continuum of disease phenotypes exists with biochemical overlap that increases with age. Improving genotype accuracy to include chimera subtyping to identify attenuated chimeras and CAH-X and consideration of P30L as a unique group are important to guide genetic counseling and provide anticipatory guidance in disease management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf546","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:09:23Z","timestamp":1759320563000},"page":"1098-1113","source":"Crossref","is-referenced-by-count":6,"title":["Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-134X","authenticated-orcid":false,"given":"Qizong","family":"Lao","sequence":"first","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Schulman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0495-0532","authenticated-orcid":false,"given":"Sarah","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kollender","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Bick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-7503","authenticated-orcid":false,"given":"Deepika","family":"Burkardt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Division of Genetics and Metabolism, Children's National Hospital , Washington, DC 20010 ,","place":["USA"]},{"name":"Department of Pediatrics and Orthopedics, George Washington University , Washington, DC 20052 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-0460","authenticated-orcid":false,"given":"Deborah P","family":"Merke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute of Child Health and Human Development Eunice Kennedy Shriver \u00a0 , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"13","key":"2026031619565776700_dgaf546-B1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"2026031619565776700_dgaf546-B2","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619565776700_dgaf546-B3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"11","key":"2026031619565776700_dgaf546-B4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet Med"},{"issue":"6","key":"2026031619565776700_dgaf546-B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2026031619565776700_dgaf546-B6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/jcem-55-5-817","article-title":"Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia","volume":"55","author":"Kohn","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026031619565776700_dgaf546-B7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1530\/EJE-11-0019","article-title":"Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families","volume":"164","author":"Nandagopal","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026031619565776700_dgaf546-B8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","article-title":"Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome","volume":"50","author":"Falhammar","year":"2015","journal-title":"Endocrine"},{"issue":"8","key":"2026031619565776700_dgaf546-B9","first-page":"2322","article-title":"Steroid 21-hydroxylase deficiency: genotype may not predict phenotype","volume":"80","author":"Wilson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026031619565776700_dgaf546-B10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data","volume":"57","author":"New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026031619565776700_dgaf546-B11","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.191.12.2183","article-title":"Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease","volume":"191","author":"Blanchong","year":"2000","journal-title":"J Exp Med"},{"key":"2026031619565776700_dgaf546-B12","doi-asserted-by":"crossref","first-page":"709758","DOI":"10.3389\/fendo.2021.709758","article-title":"Genes and pseudogenes: complexity of the RCCX locus and disease","volume":"12","author":"Carrozza","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2026031619565776700_dgaf546-B13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","article-title":"EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency","volume":"28","author":"Baumgartner-Parzer","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2026031619565776700_dgaf546-B14","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026031619565776700_dgaf546-B15","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026031619565776700_dgaf546-B16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/humu.23351","article-title":"CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants","volume":"39","author":"Simonetti","year":"2018","journal-title":"Hum Mutat"},{"issue":"12","key":"2026031619565776700_dgaf546-B17","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/jc.85.12.4562","article-title":"How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency","volume":"85","author":"L'Allemand","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026031619565776700_dgaf546-B18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2011.174037","article-title":"Junction site analysis of chimeric CYP21A1P\/CYP21A2 genes in 21-hydroxylase deficiency","volume":"58","author":"Chen","year":"2012","journal-title":"Clin Chem"},{"issue":"7","key":"2026031619565776700_dgaf546-B19","doi-asserted-by":"crossref","first-page":"e2195","DOI":"10.1002\/mgg3.2195","article-title":"Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P\/CYP21A2 chimera","volume":"11","author":"Lao","year":"2023","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"2026031619565776700_dgaf546-B20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0997-104","article-title":"Tenascin-X deficiency is associated with Ehlers-Danlos syndrome","volume":"17","author":"Burch","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"2026031619565776700_dgaf546-B21","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1210\/jc.2012-3148","article-title":"Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"98","author":"Merke","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026031619565776700_dgaf546-B22","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","article-title":"Broadening the spectrum of Ehlers Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"100","author":"Morissette","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026031619565776700_dgaf546-B23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/humu.23028","article-title":"Ehlers-danlos syndrome caused by biallelic TNXB variants in patients with congenital adrenal hyperplasia","volume":"37","author":"Chen","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"2026031619565776700_dgaf546-B24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000481911","article-title":"Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome","volume":"89","author":"Miller","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2026031619565776700_dgaf546-B25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jmoldx.2019.06.001","article-title":"High-throughput screening for CYP21A1P-TNXA\/TNXB chimeric genes responsible for ehlers-danlos syndrome in patients with congenital adrenal hyperplasia","volume":"21","author":"Lao","year":"2019","journal-title":"J Mol Diagn"},{"issue":"7","key":"2026031619565776700_dgaf546-B26","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1210\/clinem\/dgaa199","article-title":"The prevalence of the chimeric TNXA\/TNXB gene and clinical symptoms of ehlers-danlos syndrome with 21-hydroxylase deficiency","volume":"105","author":"Gao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026031619565776700_dgaf546-B27","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1210\/clinem\/dgab033","article-title":"Ehlers-danlos syndrome: molecular and clinical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia","volume":"106","author":"Marino","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026031619565776700_dgaf546-B28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jmoldx.2013.06.001","article-title":"Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia","volume":"15","author":"Xu","year":"2013","journal-title":"J Mol Diagn"},{"issue":"2","key":"2026031619565776700_dgaf546-B29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"issue":"3","key":"2026031619565776700_dgaf546-B30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619565776700_dgaf546-B31","first-page":"1145","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation","volume":"78","author":"Wedell","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031619565776700_dgaf546-B32","doi-asserted-by":"crossref","first-page":"1015773","DOI":"10.3389\/fendo.2022.1015773","article-title":"The underlying cause of the simple virilizing phenotype in patients with 21-hydroxylase deficiency harboring P31L variant","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026031619565776700_dgaf546-B33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-020-02323-3","article-title":"Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"69","author":"Kocova","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"2026031619565776700_dgaf546-B34","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1002\/mgg3.1556","article-title":"A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"9","author":"Lao","year":"2021","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"2026031619565776700_dgaf546-B35","doi-asserted-by":"crossref","first-page":"e2835","DOI":"10.1210\/clinem\/dgab280","article-title":"Letter to the editor from lao and merke: \u201cEhlers-Danlos syndrome: molecular and clirnical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia\u201d","volume":"106","author":"Lao","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026031619565776700_dgaf546-B36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41431-021-00870-5","article-title":"Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras","volume":"29","author":"Lao","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2026031619565776700_dgaf546-B37","first-page":"1505","article-title":"Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency","volume":"84","author":"Nordenstr\u00f6m","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026031619565776700_dgaf546-B38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MOP.0b013e32834810a4","article-title":"Adult women with 21-hydroxylase deficient congenital adrenal hyperplasia, surgical and psychological aspects","volume":"23","author":"Nordenstr\u00f6m","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2026031619565776700_dgaf546-B39","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1210\/clinem\/dgaa801","article-title":"Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: a population-based cohort study","volume":"106","author":"Hirschberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026031619565776700_dgaf546-B40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","article-title":"Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate","volume":"70","author":"Caster\u00e0s","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026031619565776700_dgaf546-B41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2265.2011.04151.x","article-title":"High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency","volume":"75","author":"Nermoen","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026031619565776700_dgaf546-B42","doi-asserted-by":"crossref","first-page":"1472516","DOI":"10.3389\/fgene.2024.1472516","article-title":"Comparison of long-read sequencing and MLPA combined with long-PCR sequencing of CYP21A2 mutations in patients with 21-OHD","volume":"15:","author":"Lan","year":"2024","journal-title":"Front Genet"},{"issue":"7","key":"2026031619565776700_dgaf546-B43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/clinchem\/hvac046","article-title":"Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing","volume":"68","author":"Liu","year":"2022","journal-title":"Clin Chem"},{"issue":"7","key":"2026031619565776700_dgaf546-B44","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/clinem\/dgac187","article-title":"Long-read amplicon sequencing of the CYP21A2 in 48 Thai patients with steroid 21-hydroxylase deficiency","volume":"107","author":"Tantirukdham","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026031619565776700_dgaf546-B45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/clinem\/dgad577","article-title":"A MinION-based long-read sequencing application with one-step PCR for the genetic diagnosis of 21-hydroxylase deficiency","volume":"109","author":"Adachi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026031619565776700_dgaf546-B46","doi-asserted-by":"crossref","first-page":"e3322","DOI":"10.1210\/clinem\/dgae819","article-title":"Chimeric CYP21A1P\/CYP21A2 genes in 21-hydroxylase deficiency detected by long-read sequencing and phenotypes correlation","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf546\/64519320\/dgaf546.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1098\/64519320\/dgaf546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1098\/64519320\/dgaf546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:57:12Z","timestamp":1773705432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/1098\/8275811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf546","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,6]]}}}